FDA asks J&J’s DePuy to recall unused custom implants

August 24, 2012 by MassDevice staff

Johnson & Johnson subsidiary DePuy Orthopedics recalls all unused custom implants, a product line the company discontinued after receiving an FDA warning letter late last year.

DePuy logo

Following an FDA request, Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics launched a recall of all unused units of its customer orthopedic implants, a product line the company shut down in January.

DePuy in January announced it would discontinue its custom orthopedics division after in response to an FDA warning following an inspection of the Warsaw, Ind.-based company’s facilities.

The FDA ordered DePuy to notify surgeons that the federal watchdog agency had identified concerns with the implants, and further asked the device maker to take steps to retrieve all remaining unused devices, according to a DePuy letter sent to physicians.

DePuy has sold more than 8,300 customer units since 1999, spokeswoman Mindy Tinsley told in an email today. The recall affects only unused implants, for which no number was given.

“Devices meeting the regulatory definition of a custom medical device are those which are provided by prescription at a physician’s request to meet a specific patient need and have been exempt from FDA premarket review under the Federal Food, Drug, & Cosmetic Act since 1976,” according to the physician letter. “The agency has identified concerns about DePuy Orthopaedics’ interpretation of the custom device definition.”

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button